Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/31742
Title: Protective effects of melatonin in experimental free radical-related ocular diseases
Authors: Siu, AW
Maldonado, M
Sanchez-Hidalgo, M
Tan, DX
Reiter, RJ
Keywords: Antioxidant
Cataract
Ischemia/reperfusion
Keratitis
Melatonin
Retinopathy
Issue Date: 2006
Publisher: Blackwell Publishing
Source: Journal of pineal research, 2006, v. 40, no. 2, p. 101-109 How to cite?
Journal: Journal of Pineal Research 
Abstract: Melatonin (N-acetyl-5-methoxytryptamine) is an indoleamine with a range of antioxidative properties. Melatonin is endogenously produced in the eye and in other organs. Current evidence suggests that melatonin may act as a protective agent in ocular conditions such as photo-keratitis, cataract, glaucoma, retinopathy of prematurity and ischemia/reperfusion injury. These diseases are sight-threatening and they currently remain, for the most part, untreatable. The pathogenesis of these conditions is not entirely clear but oxidative stress has been proposed as one of the causative factors. Elevated levels of various reactive oxygen and nitrogen species have been identified in diseased ocular structures. These reactants damage the structure and deplete the eye of natural defense systems, such as the antioxidant, reduced glutathione, and the antioxidant enzyme superoxide dismutase. Oxidative damage in the eye leads to apoptotic degeneration of retinal neurons and fluid accumulation. Retinal degeneration decreases visual sensitivity and even a small change in the fluid content of the cornea and crystalline lens is sufficient to disrupt ocular transparency. In the eye, melatonin is produced in the retina and in the ciliary body. Continuous regeneration of melatonin in the eye offers a frontier antioxidative defense for both the anterior and posterior eye. However, melatonin production is minimal in newborns and its production gradually wanes in aging individuals as indicated by the large drop in circulating blood concentrations of the indoleamine. These individuals are possibly at risk of contracting degenerative eye diseases that are free radical-based. Supplementation with melatonin, a potent antioxidant, in especially the aged population should be considered as a prophylaxis to preserve visual functions. It may benefit many individuals worldwide, especially in countries where access to medical facilities is limited.
URI: http://hdl.handle.net/10397/31742
ISSN: 0742-3098
DOI: 10.1111/j.1600-079X.2005.00304.x
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

SCOPUSTM   
Citations

114
Last Week
0
Last month
1
Citations as of Oct 8, 2017

WEB OF SCIENCETM
Citations

104
Last Week
2
Last month
0
Citations as of Oct 15, 2017

Page view(s)

33
Last Week
0
Last month
Checked on Oct 15, 2017

Google ScholarTM

Check

Altmetric



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.